Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells
Fig 5
Muc1-Bi-1 and Muc1-Bi-2 mediate specific cytotoxic activities (E:T ratio = 10:1).
Cytotoxicity assays were performed as described in the Materials and Method. Muc1-Bi-1 and Muc1-Bi-2 were incubated with different cell lines in the presence of PBMCs. The effector cells (PBMCs) (25000 cells/well) and target cells, CHO, HT29, LS174T, and SKOV3 (2500 cells/well) at ratio of 10:1 (E:T ratio = 10:1). Data are means ± SD, * P < 0.05; ** P < 0.01 compared with control.